Evolution in the real-world therapeutic strategies in more than 20,000 women with breast cancer having received human epidermal growth factor receptor 2–targeted treatments: Results from the french personalized reimbursement model database (2011–2018)

Autor: Xavier Pivot, Anne Doly, Julien Manson, L. Samelson, Paul Cottu, Olivier Aujoulat, Hugues Barletta, Nassera Chalabi, Bruno Coudert, David Pérol

Publikováno v: European Journal of Cancer
European Journal of Cancer, 2020, 141, pp.209-217. ⟨10.1016/j.ejca.2020.10.012⟩
European Journal of Cancer, Elsevier, 2020, 141, pp.209-217. ⟨10.1016/j.ejca.2020.10.012⟩

International audience; Background: There is a growing need for real-world data on cancer treatments usage, especially to assess compliance with recommendations. We developed a French project using hospital data to analyse evolution in the therapeuti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce1dd8c8aad413817f10cd639114d74c
https://hal.science/hal-03493774

The Personalised Reimbursement Models (Prm): Real World Data Collection to Provide Innovative Pricing Solutions in France

Autor: Bruno Coudert, O Aujoulat, D Azria, J Pinguet, A Doly, J Manson, R Montastier, H Barletta, X Pivot, N Grandfils, D Perol, V. Machuron, L. Samelson, B Tehard, Paul-Henri Cottu

Publikováno v: Value in Health. 20:A743

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d7038539e89df93feee05af29f155294
https://doi.org/10.1016/j.jval.2017.08.2058

Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin

Autor: Philippe Wolf, Didier Samuel, Karim Boudjema, Christophe Duvoux, Lionel Rostaing, Olivier Boillot, Claire Vanlemmens, Yvon Calmus, Martine Neau-Cransac, Jean Gugenheim, Danielle Botta-Fridlund, Georges Philippe Pageaux, François Durand, Olivier Chazouillères, Sébastien Dharancy, L. Samelson

Publikováno v: Journal of Hepatology
Journal of Hepatology, 2012, 57 (3), pp.564-71. ⟨10.1016/j.jhep.2012.04.022⟩
Journal of Hepatology, Elsevier, 2012, 57 (3), pp.564-71. ⟨10.1016/j.jhep.2012.04.022⟩

International audience; BACKGROUND & AIMS: We aimed at determining the effect of maintenance therapy with ribavirin alone, after a year of combined peginterferon-alfa 2a (PegIFNα-2a) and ribavirin therapy, on viral response and liver histology after

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8384f0a40dadee44e9270fadb1a3a759
https://hal.science/hal-00865405

[Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences]

Autor: F, Roudot-Thoraval, A, Abergel, F, Allaert, M, Bourlière, H, Desmorat, F, Fagnani, T, Fontanges, A, Hanana, S, Pol, J P, Zarski, C, Rousseaux, C, Gandossi, L, Samelson, S, Dole, S, Dantin, F, Eberlé, M F, Saint-Marc-Girardin, L, Abelsour

Publikováno v: Gastroenterologie clinique et biologique. 25(12)

The aim of this observational study in patients with chronic hepatitis C and treated with interferon alpha-2a was to assess 1) monitoring in everyday practice, 2) the acceptability of treatment and 3) the intensity of fatigue.Three hundred and fifty

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3fa0a20c9bffaf8cf9f0fce75737768e
https://pubmed.ncbi.nlm.nih.gov/11910986

The Thoracic Vent

Autor: Edward Goldberg, Mark K. Ferguson, Scott L. Samelson

Publikováno v: Chest. 100:880-882

We report recent experience with a new device, the thoracic vent, in the management of simple pneumothorax. There were 16 patients aged 19 to 73 years who suffered pneumothorax due to spontaneous (4), traumatic (3), or iatrogenic (9) causes. Ease of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e714edfa79325d1f0c0212f40367d872
https://doi.org/10.1378/chest.100.3.880